Skip to main content
Log in

Gastrointestinal endocrine tumors: Recent developments

  • Review
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Endocrine tumors of the gastrointestinal tract are a heterogeneous population of neoplasms differing from each other by their secretory and functional properties, pathogenetic mechanisms, related clinical syndromes, pathological associations, and prognosis. Although such heterogeneity and the relative rarity of these tumors hamper systematic investigations, significant advances in several aspects of tumor pathology have been achieved in recent years. This article focuses on the genetic background of tumor development with emphasis on the role of the MEN-1 oncosuppressor gene in either MEN-1-associated or sporadic endocrine tumors, on the identification and pathologic relevance of tumor-produced growth factors, and on the mechanism of induction of gastrin-dependent ECL cell carcinoids of the stomach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Solcia E, Fiocca R, Rindi G, Villani L, Cornaggia M, Capella C. The pathology of the gastrointestinal endocrine system. Endocrinol Metab Clin North Am 22: 795–821, 1993.

    PubMed  CAS  Google Scholar 

  2. Dayal Y. Endocrine pathology of the gut and pancreas. Boca Raton: CRC, 1991.

    Google Scholar 

  3. Solci E, Rindi G, Sessa F, Fiocca R, Lunetti O, Bosi F. Endocrine tumors of the gastrointestinal tract. In: Polak JM, ed. Diagnostic histopathology of neuroendocrine tumors. Edinburgh: Churchill Livingstone, 1993; 123–149.

    Google Scholar 

  4. Capella C, Heitz PU, Höfler H, Solcia E, Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Solcia E, Rindi G, Fiocca R, Villani L, Buffa R, Ambrosiani L, et al. Distinct patterns of chronic gastritis associated with carcinoid, neuroendocrine carcinoma or ordinary cancer and their role in tumorigenesis. Yale J Biol Med 65:793–804, 1992.

    PubMed  CAS  Google Scholar 

  6. Bordi C, D'Adda T, Azzoni C, Pilato FP, Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. Am J Surg Pathol 19 (Suppl 1):S8-S19, 1995.

    PubMed  Google Scholar 

  7. Rindi G, Bordi C, Rappel S, La Rosa S, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. Clinicopathologic analysis of 205 cases. World J Surg 20:158–172, 1996.

    Article  Google Scholar 

  8. Bordi C, Falchetti A, Azzoni C, D'Adda T, Canavese G, Guariglia A, et al. Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. Am J Surg Pathol 21:1075–1082, 1997.

    Article  PubMed  CAS  Google Scholar 

  9. Bordi C. Endocrine tumours of the stomach. Pathol Res Pract 191:373–380, 1995.

    PubMed  CAS  Google Scholar 

  10. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 322:723–727, 1990.

    Article  PubMed  CAS  Google Scholar 

  11. Lundqvist M, Wilander E. A study of the histopathogenesis of carcinoid tumors of the small intestine and appendix. Cancer 60:201–206, 1987.

    Article  PubMed  CAS  Google Scholar 

  12. Fiocca R, Rindi G, Capella C, Grimelius L, Polak JM, Yanaihara N, et al. Glucagon, glicentin, proglucagon, PYY, PP and pro-PP-icosapeptide immunoreactivities of rectal carcinoid tumours and related nontumour cells. Regul Pept 29:9–29, 1987.

    Article  Google Scholar 

  13. Brandi ML, Bordi C, Falchetti A, Tonelli F, Marx SJ. Multiple endocrine neoplasia type 1. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. San Diego: Academic, 1996; 783–797.

    Google Scholar 

  14. Larsson C, Skogseid B, Öberg K, Nakamura Y, Nordenskjöld M. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332:85–87, 1988.

    Article  PubMed  CAS  Google Scholar 

  15. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276:404–407, 1997.

    Article  PubMed  CAS  Google Scholar 

  16. Lubensky IA, Debelenko LV, Zhuang ZP, Emmert-Buck MR, Dong Q, Chandrasekharappa SC, et al. Allelic deletions on chromosome 11q13 in multiple tumors from individual MEN1 patients. Cancer Res 56:5272–5278, 1996.

    PubMed  CAS  Google Scholar 

  17. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type-1 gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 105:579–582, 1993.

    PubMed  CAS  Google Scholar 

  18. Beckers A, Abs R, Reyniers E, De Boulle K, Stevenaert A, Heller FR, et al. Variable regions of chromosome 11 loss in different pathological tissues of a patient with the multiple endocrine neoplasia type I syndrome. J Clin Endocrinol Metab 79:1498–1502, 1994.

    Article  PubMed  CAS  Google Scholar 

  19. Debelenko LV, Emmert-Buck MR, Zhuang ZP, Epshteyn E, Moskaluk CA, Jensen RT, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 113:773–781, 1997.

    Article  PubMed  CAS  Google Scholar 

  20. Bordi C, D'Adda T, Azzoni C, Ferraro G. Pathogenesis of ECL cell tumors in humans. Yale J Biol Med 1997, in press.

  21. Debelenko LV, Zhuang ZP, Emmert-Buck MR, Chandrasekharappa SC, Manickam P, Guru SC, et al. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors. Cancer Res 57:2238–2243, 1997.

    PubMed  CAS  Google Scholar 

  22. Jakobovitz O, Nass D, De Marco L, Barbosa AJA, Simoni FB, Rechavi G, et al. Carcinoid tumors frequently display genetic abnormalities involving chromosome 11. J Clin Endocrinol Metab 81:3164–3167, 1996.

    Article  PubMed  CAS  Google Scholar 

  23. Lohmann DR, Funk A, Niedermeyer HP, Haupel S, Höfler H. Identification of p53-gene mutations in gastrointestinal and pancreatic carcinoids by nonradioisotopic SSCA. Virchows Arch [B] 64:293–296, 1993.

    CAS  Google Scholar 

  24. Weckstrom P, Hedrum A, Makridis C, Akerstrom G, Rastad J, Scheibenpflug L, et al. Midgut carcinoids and solid carcinomas of the intestine: Differences in endocrine markers and p53 mutations. Endocr Pathol 7:273–279, 1996.

    Article  PubMed  Google Scholar 

  25. Younes N, Fulton N, Tanaka R, Wayne J, Straus FH, Kaplan EL. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Cancer 79:1804–1808, 1997.

    Article  PubMed  CAS  Google Scholar 

  26. Vortmeyer AO, Lubensky IA, Merino MJ, Wang CY, Pham T, Furth EE, et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 89:1448–1453, 1997.

    Article  PubMed  CAS  Google Scholar 

  27. Puetzal L, Lewis CE, Lorenzen J, McGee OD. Growth factors: regulation of normal and neoplastic growth. J Pathol 169:191–201, 1993.

    Article  Google Scholar 

  28. Lloyd RV. Growth factors. Endocr Pathol 8:121–127, 1997.

    Article  PubMed  CAS  Google Scholar 

  29. Lester WM, Gotlieb AI. The cardiovascular system. In: Kovacs K, Asa SL, eds. Functional endocrine pathology, vol. 2. Boston: Blackwell, 1991; 724–747.

    Google Scholar 

  30. Moettel CG, Sauer WG, Dockerty MB, Baggenstoss AH. Life history of the carcinoid tumor of the small intestine. Cancer 14:901–912, 1961.

    Article  Google Scholar 

  31. McNeal JE. Mechanism of obstruction in carcinoid tumors of the small intestine. Am J Clin Pathol 56:454–458, 1971.

    Google Scholar 

  32. Anthony PP, Drury RAB. Elastic vascular elastosis of mesenteric blood vessels in argentaffin carcinoma. J Clin Pathol 23:110–118, 1970.

    Article  PubMed  CAS  Google Scholar 

  33. Qizilbash AH. Carcinoid tumors, vascular elastosis, and ischemic disease of the small intestine. Dis Col Rect 20:554–560, 1977.

    Article  CAS  Google Scholar 

  34. Harvey JN, Denyer ME, DaCosta P. Intestinal infarction caused by carcinoid associated elastic vascular sclerosis: early presentation of a small ileal carcinoid tumour. Gut 30:691–694, 1989.

    Article  PubMed  CAS  Google Scholar 

  35. Cai YC, Barnard G, Hiestand L, Woda B, Colby J, Banner B. Florid angiogenesis in mucosa surrounding an ileal carcinoid tumor expressing transforming growth factor-alpha. Am J Surg Pathol 21:1373–1377, 1997.

    Article  PubMed  CAS  Google Scholar 

  36. Bordi C, Caruana P, D'Adda T, Azzoni C. Smooth muscle cell abnormalities associated with gastric ECL cell carcinoids. Endocr Pathol 6:103–113, 1995.

    Article  PubMed  Google Scholar 

  37. Caruana P, Azzoni C, Bertelé A, Annibale B, Franzé A, Delle Fave G, et al. Focal oxyntic gland attrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment. Histopathology 21:359–363, 1992.

    Article  PubMed  CAS  Google Scholar 

  38. Roncoroni L, Costi R, Canavese G, Violi V, Bordi C. Carcinoid tumor associated with vascular malformation as a cause of massive gastric bleeding. Am J Gastroenterol 92: 2119–2121, 1997.

    PubMed  CAS  Google Scholar 

  39. Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol 4:181–211, 1928.

    CAS  PubMed  Google Scholar 

  40. Olsen BS, Holck S. Neurogenous hyperplasia leading to appendiceal obliteration: an immunohistochemical study of 237 cases. Histopathology 11:843–849, 1987.

    Article  PubMed  CAS  Google Scholar 

  41. Beauchamp RD, Coffey RJ, Lyons RM, Perkett EA, Townsend CM, Moses HL. Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth. Cancer Res 51:5253–5260, 1991.

    PubMed  CAS  Google Scholar 

  42. Nilsson O, Wängberg B, Kölby L, Schultz GS, Ahlman H. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours. Int J Cancer 60:645–651, 1995.

    Article  PubMed  CAS  Google Scholar 

  43. Krishnamurthy S, Dayal Y. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids. Am J Surg Pathol 21:327–333, 1997.

    Article  PubMed  CAS  Google Scholar 

  44. Chaudhry A, Öberg K, Gobl A, Heldin C-H, Funa K. Expression of transforming growth factors β1, β2, β3 in neuroendocrine tumors of the digestive system. Anticancer Res 14:2085–2091, 1994.

    PubMed  CAS  Google Scholar 

  45. Ahlman H, Wangberg B, Nilsson O. Growth regulation in carcinoid tumors. Endocrinol Metab Clin North Am 22:889–915, 1993.

    PubMed  CAS  Google Scholar 

  46. Waltenberger J, Lundin L, Öberg K, Wilander E, Miyazono K, Heldin C-H, et al. Involvement of transforming growth factor-β in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol 142:71–78, 1993.

    PubMed  CAS  Google Scholar 

  47. Nilsson O, Wangberg B, Mcrae A, Dahlstrom A, Ahlman H. Growth factors and carcinoid tumors. Acta Oncol 32:115–124, 1993.

    Article  PubMed  CAS  Google Scholar 

  48. Chaudhry A, Papanicolau V, Öberg K, Heldin C-H, Funa K. Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system. Cancer Res 52:1006–1012, 1992.

    PubMed  CAS  Google Scholar 

  49. Goldfarb M. The fibroblast growth factor family. Cell Growth Diff 1:439–445, 1990.

    PubMed  CAS  Google Scholar 

  50. Unsicker K, Reichert-Preibish H, Schmidt R, Pettman B, Labourdette G, Sensenbrenner M. Astroglial and fibroblast growth factors have neurotrophic functions for cultured peripheral and central nervous system neurons. Cell Tissue Res 84:5459–5463, 1987.

    CAS  Google Scholar 

  51. Wanaka A, Johnson EM, Milbrandt J. Localization of aFGF receptor mRNA in the adult rat central nervous system neurons by in situ hybridization. Neuron 5:267–281, 1990.

    Article  PubMed  CAS  Google Scholar 

  52. Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, et al. Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type-1—relation to pituitary tumor. J Clin Endocrinol Metab 76:1182–1187, 1993.

    Article  PubMed  CAS  Google Scholar 

  53. Brandi ML., Aurbach GD, Fitzpatrick LA, Quarto R, Spiegel AM, Bliziotes MM, et al.. Parathyroid mitogenic activity in plasma from patients with familial multiple endocrine neoplasia type 1. N Engl J Med 314:1287–1293, 1986.

    Article  PubMed  CAS  Google Scholar 

  54. La Rosa S, Chiaravalli AM, Capella C, Uccella S, Sessa F. Immunohistochemical localization of acidic fibroblast growth factor in normal human enterochromaffin cells and related gastrointestinal tumours. Virchows Arch 430:117–124, 1997.

    Article  PubMed  Google Scholar 

  55. Bordi C, Falchetti A, Buffa R, Azzoni C, D'Adda T, Caruana P, et al.. Production of basic fibroblast growth factor by gastric carcinoid tumors, and their putative cells of origin. Hum Pathol 25:175–180, 1994.

    Article  PubMed  CAS  Google Scholar 

  56. Chaudhyr A, Funa K, Öberg K. Expression of growth factor peptides and their receptors in neuroendocrine tumors of the digestive system. Acta Oncol 32:107–114, 1993.

    Article  Google Scholar 

  57. Hanneken A, Baird A. Immunolocalization of basic fibroblast growth factor—dependence on antibody type and tissue fixation. Exp Eye Res 54:1011–1014, 1992.

    Article  PubMed  CAS  Google Scholar 

  58. Nilsson O, Dahlström A, Grönstad K-O, Rosengren L, Briving C, Skolnik G, et al. Successful transplantation of a human midgut carcinoid tumour to the anterior eye chamber of the rat. Acta Physiol Scand 120:317–319, 1984.

    Article  PubMed  CAS  Google Scholar 

  59. Theodorsson E, Ryberg B, Nilsson O, Ericson LE, Dahlström A, Ahlman H. Intraocular transplants of a human gastrinoma in immuno-suppressed rats: morphological, chromato-graphic and functional studies. Regul Pept 24:97–110, 1989.

    Article  PubMed  CAS  Google Scholar 

  60. Wigander A, Lundmark K, McRae A, Mölne J, Nilsson O, Haglid K, et al.. Production of transferable neuronotrophic factor(s) by human midgut carcinoid tumour cells; studies using cultures of rat fetal cholinergic neurons. Acta Physiol Scand, 141:107–117, 1991.

    PubMed  CAS  Google Scholar 

  61. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, et al.. Histopathological classification of nonantral gastric endocrine growths in man. Digestion 41: 185–200, 1988.

    PubMed  CAS  Google Scholar 

  62. Tang LH, Modlin IM, Lawton GP, Kidd M, Chinery R. The role of transforming growth factor alpha in the enterochromaffin-like cell tumor autonomy in an African rodent mastomys. Gastroenterology 111:1212–1223, 1996.

    Article  PubMed  CAS  Google Scholar 

  63. H»kanson R, Sundler F. The gastrin concept: the proposed mechanism behind the development of drug-induced gastric carcinoids. In: H»kanson R, Sundler F, eds. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991;449–460.

    Google Scholar 

  64. H»kanson R, Ekelund M, Sundler F. Activation and proliferation of gastric endocrine cells. In: Falkmer S, H»kanson R, Sundler F, eds. Evolution and tumor pathology of the neuroendocrine system. Amsterdam: Elsevier, 1984;371–398.

    Google Scholar 

  65. H»kanson R, Tielemans Y, Chen D, Andersson K, Mattsson H Sundler F. Time-dependent changes in enterochromaffinlike cell kinetics in stomach of hypergastrinemic rats. Gastroenterology 105:15–21, 1993.

    Google Scholar 

  66. Hirschowitz BI, Griffith J, Pellegrin D, Cummings OW. Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy. Gastroenterology 102:1409–1418, 1992.

    PubMed  CAS  Google Scholar 

  67. Bordi C, Azzoni C, D'Adda T, Bertelè A, Volpi R, Franzè A. Endocrine cell replacement of oxyntic glands in Zollinger-Ellison syndrome: a role for female sex hormones? Endocr Pathol 6:345–354, 1995.

    Article  PubMed  Google Scholar 

  68. Reed JC. Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance. Curr Opinion Oncol 7:541–546, 1995.

    Article  CAS  Google Scholar 

  69. Azzoni C, Doglioni C, Viale G, Delle Fave G, Deboni M., Caruana P, et al.. Involvement of BCL-2 oncoprotein in the development of enterochromaffin-like cell gastric carcinoids. Am J Surg Pathol 20:433–441, 1996.

    Article  PubMed  CAS  Google Scholar 

  70. Bordi C, Pilato FP, Bertelé A, D'Adda T, Missale G. Expression of glycoprotein hormone alpha-subunit by endocrine cells of the oxyntic mucosa is associated with hypergastrinemia. Hum Pathol 19:580–585, 1988.

    Article  PubMed  CAS  Google Scholar 

  71. Heitz PU, Kasper M, Klöppel G, Polak JM, Vaitukaitis JL. Glycoprotein-hormone alphachain production by pancreatic endocrine tumors: a specific marker for malignancy. Immunocytochemical analysis of tumors of 155 patients. Cancer 51:277–282, 1983.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cesare Bordi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bordi, C., D'Adda, T., Azzoni, C. et al. Gastrointestinal endocrine tumors: Recent developments. Endocr Pathol 9, 99–115 (1998). https://doi.org/10.1007/BF02782603

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02782603

Key Words

Navigation